2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness
Milton, Mark, Dodge, Robert and Potthoff, Bernd (2022) 2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness. Bioanalysis.
Abstract
No Abstract.
Gene Therapy, Cell Therapy and Vaccines (9 Topics)
1.	TAb/NAb & Anti-Viral Vector Antibody Companion Diagnostic Assays 
2.	Viral Vector Shedding Assays 
3.	Viral Vector Gene Therapy Immunogenicity & Pre-Existing Immunity 
4.	CRISPR/Cas9 Immunogenicity & Bioanalytical Challenges 
5.	CAR-T Immunogenicity & Cellular Kinetics 
6.	qPCR/ddPCR Assay Performance 
7.	Analyte Stability in Vaccine Serology Assays 
8.	Vaccine Critical Reagent Management and Bridging 
9.	Vaccine Bioanalytical Assays & Immune Monitoring
Immunogenicity of Biotherapeutics (8 Topics)
1.	NAb Assays – Drug and Target Interference 
2.	ADA Cut Points – Appropriateness and False Positive Rates 
3.	Circulating Immune Complexes – ADA/Drug Complexes 
4.	ADA Assay Comparability 
5.	Integrated Summary of Immunogenicity Harmonization 
6.	China NMPA Immunogenicity Guidance 
7.	Multi-Domain Biotherapeutics & Bispecific Antibody Immunogenicity
8.	Biosimilar ADA Assay Validation & Harmonization
| Item Type: | Article | 
|---|---|
| Date Deposited: | 05 Jul 2022 00:45 | 
| Last Modified: | 05 Jul 2022 00:45 | 
| URI: | https://oak.novartis.com/id/eprint/46981 | 
 Tools
 Tools Tools
 Tools